Sheffield ME & Fibromyalgia Group We are excited to be hosting Dr. David Tuller, DrPH, discussing scientific integrity and clinical trials in...
This morning, Professor Racaniello sent the following e-mail to Richard Horton, editor of The Lancet. The subject heading: “Another open letter...
From the start, one of my strategies for this PACE-debunking project was to draw in outside experts–people with no ax to grind and no...
On March 27th, Professor Racaniello and I sent an e-mail to Dr. Trish Groves, editor-in-chief at BMJ Open, declining her request that we send in...
On February 20th, Carol Monaghan, a member of Parliament from the Scottish National Party, led an extraordinary debate in the House of Commons...
There are three posts on Emerges FB in reverse order. This is the correct order: Video 1 [MEDIA] Video 2 [MEDIA] Video 3 [MEDIA] note: you...
So I arrived in Melbourne on Wednesday afternoon. I’ll be in Australia for several weeks for meetings, interviews and general...
So I’ve been asked about my plans after June 30th, which is the end of the period covered by last year’s crowdfunding campaign. There’s been...
by Amy Maxmen After decades of pleading, people with the condition have finally caught the attention of mainstream science — and dozens of...
In 2015 David Tuller, DrPH, a Senior Fellow in Public Health in Journalism at the Center of Global Public Health, School of Public Health at...
On September 20, 2017, a BMJ Publishing Group journal, Archives of Disease in Childhood published the SMILE trial. This trial investigated an...
So let’s talk about Professor Esther Crawley’s SMILE trial, published in September by the journal Archives of Disease in Childhood, one of the BMJ...
After receiving the letter [Ms. Paterson's], I decided it would be a good idea to review all my blog posts, as well as the various e-mails I had...
Earlier today, I e-mailed the following letter to Sue Paterson, University of Bristol’s Director of Legal Services, to clarify whether or not I...
A few days ago, I received Sir Andrew’s response. He indicated that the current guidance remains in effect while NICE undergoes the process of...
I would like to congratulate NICE on its decision to pursue a full update of CG53, the CFS/ME guidance, rather than accept the surveillance...
Separate names with a comma.
